DPP6 as a candidate gene for neuroleptic-induced tardive dyskinesia
Open Access
- 9 August 2011
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 13 (1) , 27-34
Abstract
We implemented a two-step approach to detect potential predictor gene variants for neuroleptic-induced tardive dyskinesia (TD) in schizophrenic subjects. First, we screened associations by using a genome-wide (Illumina HumanHapCNV370) SNP array in 61 Japanese schizophrenia patients with treatment-resistant TD and 61 Japanese schizophrenia patients without TD. Next, we performed a replication analysis in 36 treatment-resistant TD and 138 non-TD subjects. An association of an SNP in the DPP6 (dipeptidyl peptidase-like protein-6) gene, rs6977820, the most promising association identified by the screen, was significant in the replication sample (allelic P=0.008 in the replication sample, allelic P=4.6 × 10−6, odds ratio 2.32 in the combined sample). The SNP is located in intron-1 of the DPP6 gene and the risk allele was associated with decreased DPP6 gene expression in the human postmortem prefrontal cortex. Chronic administration of haloperidol increased Dpp6 expression in mouse brains. DPP6 is an auxiliary subunit of Kv4 and regulates the properties of Kv4, which regulates the activity of dopaminergic neurons. The findings of this study indicate that an altered response of Kv4/DPP6 to long-term neuroleptic administration is involved in neuroleptic-induced TD.Keywords
This publication has 32 references indexed in Scilit:
- Pathway-based association analysis of genome-wide screening data suggest that genes associated with the γ-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesiaPharmacogenetics and Genomics, 2008
- Tardive dyskinesia and new antipsychoticsCurrent Opinion in Psychiatry, 2008
- Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychoticsThe British Journal of Psychiatry, 2007
- Tardive dyskinesia: eliminated, forgotten, or overshadowed?Current Opinion in Psychiatry, 2007
- The effect of atypical versus typical antipsychotics on tardive dyskinesiaEuropean Archives of Psychiatry and Clinical Neuroscience, 2006
- Evidence That Early Extrapyramidal Symptoms Predict Later Tardive Dyskinesia: A Prospective Analysis of 10,000 Patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) StudyAmerican Journal of Psychiatry, 2006
- Pharmacogenetics of Psychotropic Drug ResponseAmerican Journal of Psychiatry, 2004
- Clinical implications of pharmacogenomics for tardive dyskinesiaThe Pharmacogenomics Journal, 2004
- Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesiaActa Psychiatrica Scandinavica, 1996
- Smoking and movement disorders in psychiatric patientsBiological Psychiatry, 1991